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RATIONALE: chronic spontaneous urticaria (CSU) is a common skin
disorder characterized by the emergence of hives for at least six weeks
without any known etiologic agent. Indoleamine 2,3- dioxygenase (IDO)
which catalyzes tryptophan (Trp) to kynorenin (KYN) is an immunome-
dulatory enzyme and complicated in immunological diseases. This study,
Trp, KYN and IDO gene expression in CSU patients were analyzed.
METHODS: we studied 20 CSU patients (mean age: 2866 years, mean
duration: 2764 month) and 20 healthy individuals (mean age: 2869).
Peripheral blood mononuclear cells (PBMCs) were isolated from both
patients and healthy control and stimulated by phytohemmaglutinin
(PHA). Real-time PCR was applied to quantify IDO gene expression and
its activity was estimated by KYN/Trp ratio in supernatant of PBMCs.
RESULTS: Our study results showed that the gene expression of IDOwas
significantly higher in CSU patients (4.5660.91) compare to healthy
individuals (1.3660.52) (p50.006). Interestingly, the activity of IDO
(KYN/Trp) was decreased in CSU patients (195.63639.59) contrast of
healthy ones (663.606123.10) (p50.001).
CONCLUSIONS: Previous studies documented the impaired of IDO
gene expression in CSU patients, however in the present studywe observed
a decrease activity of IDO in CSU patients which might suggest the
function of this factor is impaired in CSU patients.
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RATIONALE: Lesions of chronic idiopathic urticaria (CIU) demonstrate
mast cell (MC) activation and recruitment of lymphocytes, eosinophils,
and basophils. CRTH2/DP2 are receptors for Prostaglandin D2 (PGD2)
expressed on infiltrating cells and induce chemotaxis and activation. Since
activated skin MC release PGD2, we explored the effects of in vitro PGD2
exposure alone or with a CRTH2 receptor antagonist (AZD1981) on the
shape change of eosinophils from active CIU patients.
METHODS: Blood was obtained from CIU patients (n515) using a JH
IRB approved protocol. Whole blood samples were incubated with buffer
or AZD1981 (0.1 or 1 mM), and then stimulated with PGD2 (10^-8 to 10^-5
M). Eosinophil shape change was examined using flow cytometry scatter
movement.
RESULTS: A net scatter movement at each PGD2 dose was plotted on a
concentration curve, and analyzed using an area under the curve (AUC)
method. Cells incubated in buffer alone had an AUC value of 119.9. Cells
exposed to 1 mM AZD1981 showed a concentration curve of 52.9 AUC
(p<0.001 from buffer alone). The cell curve at 0.1 mMAZD1981 was 76.5
AUC (p<0.001). The 50% of maximal response concentration of PGD2
required for eosinophils was 10^-7 M (buffer), 10^-6 M (1 mM AZD1981),
and 10^-6.5 M (0.1 mM AZD1981).
CONCLUSIONS: In CIU patients, PGD2 induces eosinophil shape
change at concentrations similar to healthy subjects. Preincubation with
AZD1981 markedly reduced the PGD2 mediated shape change response
indicating functional expression of CRTH2 on circulating CIU eosinophils
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RATIONALE: Evidence of mast cell (MC) degranulation and infiltration
by leukocytes such as basophils, eosinophils, and T lymphocytes is
observed in lesions in chronic idiopathic urticaria (CIU). Since activated
MCs release Prostaglandin D2 (PGD2), a possible recruitment pathway for
these leukocytes is CRTh2, a receptor for PGD2. We compared CRTh2
expression on leukocytes in the blood of CIU and healthy subjects.
METHODS: We recruited adult CIU subjects (n520) and nonatopic
subjects (n58) and examined basal expression of CRTH2 via flow
cytometry. Basophils and eosinophils were gated using scatter and specific
markers. Values are reported as Median Net MFI (6 SEM). Data were
analyzed using Mann-Whitney Test.
RESULTS: CRTh2 expression was significantly decreased on basophils
from CIU subjects as compared with healthy controls (307.1 6 21.11 vs
398.46 29.41, p50.0395). CRTh2 surface expression on eosinophils from
CIU subjects also trended lower as compared to controls (61.186 4.197 vs
70.886 6.77, p50.0524). CRTh2 expression levels were more variable on
basophils and eosinophils in CIU subjects as compared to controls. There
was no difference between the percentage of basophils or eosinophils
expressing CRTh2 in CIU compared with controls.
CONCLUSIONS: CRTh2 expression on leukocytes from CIU subjects is
more variable than healthy controls. Levels on blood basophils are
significantly reduced, compared to nonatopic controls. Eosinophil
CRTh2 levels were overall lower than basophils and trended lower in
CIU subjects. These findings suggest that the CRTh2 pathway may be
engaged in the recruitment of eosinophils and basophils to CIU lesions.
